Description
Nefiracetam, Powder
Nefiracetam is a second-generation racetam compound, structurally related to piracetam and aniracetam, but distinct due to its modifications that improve its lipophilicity and membrane permeability. It is primarily studied for its cognitive-enhancing effects, particularly in the domains of memory formation, learning speed, and emotional stability.
Nefiracetam has been found to modulate several neurotransmitter systems, including acetylcholine, GABA, and glutamate, making it a candidate for improving cognitive deficits and providing anxiolytic-like benefits in various research models.
Mechanism of Action:
-
Cholinergic System Modulation: Nefiracetam enhances acetylcholine release and receptor sensitivity, particularly at muscarinic and nicotinic receptors, supporting memory and learning processes.
-
GABAergic Modulation: It modulates GABA(A) receptor function, contributing to its potential anxiolytic (anxiety-reducing) effects.
-
Glutamatergic Modulation: Nefiracetam influences NMDA receptors, facilitating long-term potentiation (LTP), a cellular mechanism fundamental to learning and memory consolidation.
Research Benefits:
-
Memory Enhancement: Nefiracetam supports both short-term and long-term memory formation by boosting cholinergic neurotransmission and promoting synaptic plasticity.
-
Cognitive Function Support: It has been researched for improving attention, learning speed, and mental clarity.
-
Anxiolytic Properties: Studies suggest that nefiracetam may reduce anxiety-like behaviors by modulating GABAergic and cholinergic systems.
-
Neuroprotection: Nefiracetam is studied for protecting neurons from oxidative stress and excitotoxicity, offering potential in neurodegenerative research models.
Scientific Studies and Applications:
-
Memory and Learning:
-
Moriguchi et al. (2003) demonstrated that Nefiracetam enhanced learning ability and improved memory performance in aged rat models via modulation of cholinergic and glutamatergic systems.
-
-
Anxiolytic Effects:
-
Research by Takahashi et al. (1996) showed that Nefiracetam exhibited significant anxiolytic effects in behavioral models without causing sedation, supporting its potential role in stress-related cognitive impairment studies.
-
-
Neuroprotection:
-
Studies such as Sakurai et al. (1996) highlighted Nefiracetam’s ability to reduce neuronal damage after ischemic events, suggesting a neuroprotective role through GABAergic and NMDA receptor modulation.
-
Role of Lipophilicity:
Compared to earlier racetams, Nefiracetam’s higher lipophilicity allows it to cross the blood-brain barrier more efficiently, enhancing its potency and duration of action in research models.